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AbstrAct
Background Electronic prescribing (ePrescribing) or 
computerised provider/physician order entry (CPOE) 
systems can improve the quality and safety of health 
services, but the translation of this into reduced harm 
for patients remains unclear. This review aimed to 
synthesise primary qualitative research relating to how 
stakeholders experience the adoption of ePrescribing/
CPOE systems in hospitals, to help better understand why 
and how healthcare organisations have not yet realised 
the full potential of such systems and to inform future 
implementations and research.
Methods We systematically searched 10 bibliographic 
databases and additional sources for citation searching 
and grey literature, with no restriction on date or 
publication language. Qualitative studies exploring 
the perspectives/experiences of stakeholders with the 
implementation, management, use and/or optimisation 
of ePrescribing/CPOE systems in hospitals were included. 
Quality assessment combined criteria from the Critical 
Appraisal Skills Programme Qualitative Checklist and the 
Standards for Reporting Qualitative Research guidelines. 
Data were synthesised thematically.
Results 79 articles were included. Stakeholders’ 
perspectives reflected a mixed set of positive and 
negative implications of engaging in ePrescribing/CPOE 
as part of their work. These were underpinned by further-
reaching change processes. Impacts reported were largely 
practice related rather than at the organisational level. 
Factors affecting the implementation process and actions 
undertaken prior to implementation were perceived as 
important in understanding ePrescribing/CPOE adoption 
and impact.
Conclusions Implementing organisations and teams 
should consider the breadth and depth of changes that 
ePrescribing/CPOE adoption can trigger rather than focus 
on discrete benefits/problems and favour implementation 
strategies that: consider the preimplementation context, 
are responsive to (and transparent about) organisational 
and stakeholder needs and agendas and which can 
be sustained effectively over time as implementations 
develop and gradually transition to routine use and 
system optimisation.
IntroductIon
The medication use process in hospital 
settings is generally understood to 
comprise four interrelated stages: 
prescribing, dispensing, administering and 
monitoring.1 In practice, these involve a 
broad range of health professionals, docu-
ments, practices, situations, settings and 
multiple inter-related processes, the inter-
play of which can give rise to several risks 
and errors with the potential to result in 
patient harm.2–5 Electronic prescribing 
(ePrescribing) or computerised provider/
physician order entry (CPOE) systems 
can improve patient safety and the quality 
of health services by reducing risks asso-
ciated with medication errors6–8 and 
by improving organisational efficiency 
and health professionals’ performance 
throughout the medication process.7 9
However, the translation of such 
improvements into reduced harm for 
patients is still unclear.8 10 It has become 
increasingly clear that the implementation 
of ePrescribing/CPOE systems may create 
unintended consequences and intro-
duce new safety issues once in use.9 11–15 
In this context, in light of the inherent 
complexity of the medication process and 
the difficulty of examining it in isolation 
from other interrelated processes and 
contextual factors, a growing body of 
qualitative research has provided insights 
into key implementation and use issues 
concerning ePrescribing/CPOE systems 
in hospital settings9 16–23 for nearly two 
decades.24 An interpretative examination 
of such body of qualitative evidence would 
enable better understanding of why and 
how healthcare organisations have not yet 
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realised the full potential of such systems and would 
inform future implementations and research. With 
this motivation, we conducted a systematic review of 
qualitative studies addressing the following question: 
how do stakeholders experience the adoption of ePre-
scribing/CPOE systems in hospitals?
We aimed to identify, collate, assess and synthesise 
primary qualitative research relating to the percep-
tions and experiences of those involved in, or affected 
by, the implementation, management, use and/or opti-
misation of ePrescribing/CPOE systems in hospital 
settings.25
The review has three important elements absent 
from previous attempts to synthesise primary qualita-
tive research on this topic26: (1) it employs an interpre-
tative (rather than aggregative) analytical approach; (2) 
it draws on all reported stakeholders’ perspectives, not 
just those of health professionals; and (3) it includes 
research at any stage of ePrescribing/CPOE adoption, 
from implementation through to routine use.
This is of particular importance given the complex, 
sociotechnical nature of ePrescribing/CPOE systems 
and the inherent difficulty of establishing the 
end-point of the implementation process. Imple-
mentation is generally understood as the transitional 
period or set of activities between the organisational 
decision to adopt an intervention and the point at 
which it becomes assimilated as routine use.27–29 This 
separation is not straightforward for interventions 
with such complexity: this judgement is multifac-
eted, highly contingent on multiple perspectives and 
context dependent. Overlaps between system imple-
mentation, routine use and system optimisation issues 
across settings and organisations are integral in the 
literature. Therefore, an interpretative examination of 
ePrescribing/CPOE across studies is important in that 
it enables incorporation of multiple perspectives and 
accommodation of a wide range of conceptualisations 
about the implementation process, in a holistic analyt-
ical approach.
Methods
We registered and published a peer-reviewed protocol25 
following ENTREQ guideline recommendations,30 
adopting systematic search methodology and thematic 
synthesis.31
search strategy
The following bibliographic databases were searched 
from inception to October 2018: MEDLINE, 
MEDLINE In Process, Embase, PsycINFO, Social 
Policy and Practice, CINAHL, The Cochrane Library 
(CDSR, DARE and CENTRAL databases), Nursing 
and Allied Health Sources, Applied Social Sciences 
Index and Abstracts and Scopus. Additional sources 
were Sciences and Social Sciences Citation Index and 
grey literature (Healthcare Management Information 
Consortium, Conference Proceedings Citation Index 
and Sociological Abstracts). Citations in relevant 
reviews and included studies were checked. Selected 
specialist journals were hand searched.
A comprehensive search strategy was developed, 
employing a combination of search filters,32 33 text 
words and index terms relating to qualitative research 
and relevant interventions, including variations and 
permutations used in similar reviews7 26 34–36 with no 
restriction on date or language. The sample strategy 
in online supplementary appendix 1 was adapted for 
each bibliographic database.
Inclusion criteria
Qualitative studies (standalone or within mixed-
methods designs) exploring stakeholder perspectives/
experiences of implementation, management, use 
and/or optimisation of ePrescribing/CPOE systems 
in hospitals were included. Any electronic system or 
subsystem involving the prescription and/or adminis-
tration phase of the medication process were included. 
Electronic systems involving other phases of the 
medication process (eg, systems for stock control) 
but not prescribing were excluded. Where CPOE 
systems allowed the ordering of anything other than 
medication, studies were excluded unless findings 
specific to medication were reported separately. Any 
types of participants/perspectives (eg, doctors, nurses, 
managers, service users and IT staff) were eligible. 
Eligible settings included hospital-based care settings 
(eg, wards, clinics, areas, specialities or whole organ-
isations). All articles were independently screened by 
two reviewers. Discrepancies were resolved by discus-
sion until consensus was reached.
Quality appraisal
Quality appraisal of included studies was conducted 
using a tool (online supplementary table 1) derived 
from the Critical Appraisal Skills Programme Qual-
itative Research Checklist37 and the Standards for 
Reporting Qualitative Research.38 The methodological 
quality of each study was independently appraised by 
two reviewers. Disagreements were resolved by discus-
sion until consensus was reached. Acknowledging the 
inherent difficulty of appraising all aspects of quality of 
qualitative research,39 studies were not excluded based 
on the quality/adequacy of the reporting. Instead, the 
quality of studies was taken into consideration during 
data synthesis40 by exploring whether any particular 
finding or group of findings were dependent, either 
exclusively or disproportionately, on one or more 
studies classed as ‘low-quality’ or ‘inadequately 
reported’.
data extraction
Articles were read in full before data were extracted and 
recorded by two reviewers using a piloted data extrac-
tion form (online supplementary table 2). Study findings 
were all text and tables labelled as 'results' or 'findings' 
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Figure 1 PRISMA flow diagram illustrating the study selection process. 
PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-
Analyses.
in each article including verbatim data extracts from 
participants and authors’ descriptions, summaries and 
interpretations of primary data. Extracted data were 
imported into NVivo V.11 to assist the coding, data 
management and data synthesis process.
data synthesis
Data were synthesised using a thematic synthesis 
approach31 with three overlapping interrelated stages: 
(1) line-by-line coding of the findings; (2) categorisa-
tion of codes into descriptive themes; and (3) develop-
ment of analytical themes to describe and/or explain 
descriptive themes.
A multiple coding strategy was employed, with the 
lead author coding the whole dataset and the remaining 
review team coding subsets to ensure all data were 
independently double-coded. Regular meetings were 
held throughout the data synthesis process to carry 
out reviewer triangulation comparing reviewer code-
books, descriptive/emerging themes and interpreta-
tions until a coding framework was agreed. This was 
then applied to the whole dataset by the lead author 
and revised and refined with the team. Subsequent 
meetings focused on: categorisation of initial codes 
into descriptive themes; development, discussion and 
agreement of analytical themes and interpretative 
framework; and discussion, refinement and establish-
ment of final synthesis findings.
results
Systematic searches yielded 5003 records, which 
were assessed against the inclusion criteria. Abstract 
screening resulted in 434 records considered eligible 
or inconclusive. Full-text articles were then retrieved 
and assessed for eligibility, with 79 papers included in 
the final synthesis (figure 1). Included papers reported 
data from 15 countries (UK=26, USA=25, the Neth-
erlands=9 and Australia=8). Study samples ranged 
from 10 to 1018 participants. Articles mainly focused 
on the perspectives of health professionals (in clinical, 
administrative, technical and leadership roles) with a 
few including other stakeholders (eg, patients, carers, 
policymakers or systems suppliers). Study settings 
included adult and paediatric acute care hospitals, 
general and community hospitals, medical and surgical 
wards and hospital-based clinics. Key characteristics of 
included studies are presented in online supplemen-
tary table 3.
Our quality assessment (table 1, online supplemen-
tary table 4) concluded that, overall, articles reported 
valuable research and credible findings. Nevertheless, 
29 of the 79 papers did not report or employ any tech-
niques to enhance trustworthiness (such as multiple 
coding or triangulation) in their data analysis process, 
adding to the inherent difficulty of appraising the 
credibility of findings. Only 10 of the 79 papers clearly 
and explicitly addressed the relationship between 
researchers and participants, with a further 16 papers 
providing only some relevant information, adding to 
the difficulty of evaluating the impact of these aspects 
on study findings.
Four overarching themes and 10 subthemes were 
generated from our analysis. Our set of analytical 
themes did not align with a sequential pattern or 
predefined stages of implementation/adoption. Included 
papers rarely stated how ‘implementation’ was under-
stood by researchers or the implementing organisation 
and, where present, definitions were extremely hetero-
geneous, ranging from examinations of the process in 
terms of specific time frames (eg, ref 41) through to 
its conceptualisation as an ongoing process (eg, refs 
42 43). Hence, data were pooled on the basis of patterns 
of analytical concerns incorporating a wide range of 
conceptualisations about the implementation process. 
Table 2 summarises our coding framework, and online 
supplementary table 5 details the distribution of our 
themes by included papers. Themes are described below 
and exemplar data extracts provided in online supple-
mentary table 6.
contextualising the implementation and impact of 
ePrescribing/cPoe in hospitals
Factors and/or actions undertaken prior to implemen-
tation were highlighted in some studies as important 
to understand the implementation and impact of ePre-
scribing/CPOE in hospitals. These illustrate the impor-
tance of allocating resources, prior to implementation, 
to prepare for both the organisational change and its 
stakeholders for changes in practice competencies and 
behaviour.
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Table 1 Summary of quality assessment of included studies (n=79)
Yes, n (%)
Partially, n 
(%) No, n (%)
Unclear, n 
(%)
Was the research problem and/or research question clearly reported/defined? 35 (44) 16 (20) 28 (35)
Was there a clear statement of the aims and/or objectives of the research? 69 (87) 7 (9) 3 (4)
Was a qualitative methodology appropriate? 63 (80) 16 (20)
Was the research design appropriate to address the aims of the research? 66 (84) 8 (10) 2 (3) 3 (4)
Was the sampling and recruitment strategy clearly defined and justified? 44 (56) 24 (30) 9 (11) 2 (3)
Was the method of data collection well described? 57 (72) 18 (23) 4 (5)
Were any techniques to enhance trustworthiness used? 38 (48) 12 (15) 15 (19) 14 (18)
Has the relationship between researchers and participants been adequately considered? 10 (13) 16 (20) 51 (65) 2 (3)
Have ethical issues been taken into consideration? 24 (30) 39 (49) 6 (8) 10 (13)
Was the data analysis/interpretation process well described and justified? 43 (54) 22 (28) 14 (18)
Was there a clear statement of findings? 69 (87) 10 (13)
Are the analysis and findings credible? 55 (70) 22 (28) 1 (1) 1 (1)
Was any conflict of interest reported? 4 (5) 75 (95)
Table 2 Set of themes and subthemes generated from included papers
Themes and subthemes Summary description
Contextualising the implementation and impact of electronic prescribing 
(ePrescribing) or computerised provider/physician order entry (CPOE) systems in 
hospitals
Authors’ descriptions/interpretations and primary data reporting on 
contextual factors and/or actions that that had taken place prior to 
system implementation.
  Preparing the organisation for change
  Preparing stakeholders for change
Factors affecting the implementation process of ePrescribing/CPOE systems Authors’ descriptions/interpretations and primary data reporting on 
process-related issues.  Factors positively impacting the implementation process
  Factors negatively impacting the implementation process
Positive and negative implications of ePrescribing/CPOE systems Authors’ descriptions/interpretations and primary data reporting on 
impact-related issues in terms of benefits/problems, both in practice 
and/or at the organisational level.
  Positive practice implications
  Negative practice implications
  Positive organisational implications
  Negative organisational implications
Mixed impacts and change processes Authors’ descriptions/interpretations and primary data reporting on 
impact-related issues that are not clear benefits/problems and/or 
focus on documenting change processes, both in practice and/or at 
the organisational levels.
  Change in practice
  Change at the organisational level
Preparing the organisation for change
A range of organisational factors were highlighted as a 
key enablers of successful implementation, including: 
defining an implementation strategy44; planning the 
change in terms of timescale, deliverability and organ-
isational/structural needs (eg, IT networks and under-
lying drug database)44–47; understanding current prac-
tice and workflows and their variability46 48 49; building 
a good relationship between hospitals and system 
suppliers44 46 ; and being able to design a system to fit 
the workflow.24
Preparing stakeholders for change
The active involvement of stakeholder groups 
across the hospital setting was seen as important in 
ensuring successful implementation. This included 
accommodating the agendas of multiple stakeholder 
groups44 46 47 and establishing ad hoc multidisciplinary 
networks47 to develop pathways48 and appraise service 
requirements against systems options45 while ensuring 
that stakeholders’ needs were met.43 44 50
Broader contextual factors such as key policy 
changes that can trigger or support project initia-
tion47 were also reported as relevant to facilitating 
and understanding successful implementation of ePre-
scribing/CPOE systems in hospital settings.
Factors affecting the implementation process of 
ePrescribing/cPoe systems
Factors positively impacting the implementation process
Top-level leadership and support were seen as key 
enablers, particularly if they could: bring in an under-
standing of the wider context and outside pressures 
within which the organisation was operating43 51–54; 
establish effective governance strategies to support 
implementation across the organisation through 
committees and working groups19 24 47 51 52; and iden-
tify and address any anticipated/emerging problems 
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and needs, such as those relating to guidance/pathway/
policy development, estimation/identification of 
resources, setting realistic time frames, workflow/prac-
tice changes and training needs.18 19 24 44 49 50 55–57
The availability of leadership roles and/or cham-
pioning individuals on the ground was also seen 
as a key enabler42 58 particularly as a way to facili-
tate longer term success by bringing about engage-
ment16 19 44 48 51–53 59 and support19 46 51 52 56 across 
stakeholder groups from early implementation. Other 
engagement/support strategies during implementation 
included the provision of ongoing training opportu-
nities18 19 24 43 53 56 which, in some cases, were seen to 
promote a sense of pride in mastering and helping to 
implement the system across stakeholder groups.48
Piloting and testing the system prior to full imple-
mentation was identified as important to ensure 
safety44 46 55 despite the risks associated with running 
two systems simultaneously (paper and electronic), 
typically minimising the transition from pilot to full 
implementation.44 46
Factors negatively impacting the implementation process
Problems were identified that could emerge during the 
implementation of ePrescribing/CPOE and hinder or 
negatively impact the implementation process. The 
nature of the reported issues was similar across studies, 
including core technical challenges (eg, appropriate 
infrastructure and availability of devices, issues relating 
to the usability of the system, alignment between system 
functionalities and hospital processes and interopera-
bility issues with other systems in use)41 43 55–57 60–64 
as well as personal challenges experienced by stake-
holders (eg, insufficient training and support during 
implementation, fear of change and anxiety associated 
with expectations, unfamiliarity and inexperience 
with the newly implemented system and contradic-
tions/conflicts resulting from recently changed roles, 
policies or pathways).19 41 42 48 56 60 62 63 These were 
seen as important because they could change attitudes 
towards the system during implementation16 41 55 and 
result in significant implementation delays21 55 or even 
deimplementation.60
Positive and negative implications of ePrescribing/
cPoe systems
Positive practice implications
Users’ experiences suggested a positive impact on 
safety, including a perceived reduction of medica-
tion-related incidents and adverse events after imple-
mentation,16 65 66 mainly due to improved acces-
sibility9 46 67 and legibility9 19 46 61 68–71 of prescrip-
tions. These benefits were echoed by patients.72 Easy, 
‘on-the-spot’ access to detailed and comprehensive 
patient history information18 52 61 73–75 was also seen as 
an important benefit, which also improved continuity 
of care. For implementations involving or consisting of 
new clinical decision support systems, safety benefits 
were also linked to the ability to access built-in order 
sets and information on drugs and doses9 67 73–77 and 
the system’s ability to prevent dosing errors9 45 47 
through an automatic alerting functionality61 78–80 at 
the time of prescribing.
Other reported benefits of eprescribing/CPOE 
related to perceived time-saving across the medica-
tion process: from faster prescribing and ordering of 
medications9 18 24 69 75 81 through to faster checking 
and supply of medicines.46 66 69 70 These time-saving 
benefits were afforded by a range of aspects brought 
in by ePrescribing/CPOE, such as the ability to access 
prescriptions remotely9 18 24 47 48 51 52 61 69 73 74 81 or 
improved legibility and completeness of prescrip-
tions.24 46 70
Several studies also reported on a range of perfor-
mance benefits other than strictly time-related effi-
ciencies, including improvement in: coordination and 
communication,18 42 47 52 70 prescribing accuracy and 
timeliness67 82 and ability to easily find, prioritise and 
track orders.9 67 70
Negative practice implications
Most reported negative practice implications involved 
a range of perceived inefficiencies (eg, excessive 
complexity of screens to complete prescriptions and 
having to log in and out of multiple systems) with 
many increasing task-time across all stages of the 
medication process9 16 18 51 52 61 67 72 73 79 81–84 and/or 
increased workloads.9 46 47 49 55 66 69 70 84–86 In some 
cases system-related inefficiencies were still expe-
rienced 1 year after implementation,18 with some 
perceiving themselves to be back to baseline levels of 
efficiency at around 2 years postimplementation81 and 
others considered unlikely to ever return to pre-CPOE 
efficiency levels.61
The lack of appropriate IT infrastructure to ensure 
the smooth and responsive functioning of a system (eg, 
integration of coexisting systems, log-in and screen-
loading times, availability of devices to interact with 
the system and provision of ongoing technical support 
to users) was seen to have disruptive consequences on 
health professionals’ workflows after the implementa-
tion of ePrescribing/CPOE.9 24 47 48 51 52 61 68 75 80 84 86–88
Negative practice implications were often 
perceived to counterbalance the benefits of ePre-
scribing/CPOE from a clinical perspective, partic-
ularly where the implementation of ePrescribing/
CPOE was also associated with the introduction 
of new, unintended and often unanticipated safety 
risks.9 14 18 19 42 43 49 61 63 65 68 71 73 75 76 78 81 83–86 88–93 For 
example, a number of issues relating to systems’ inter-
faces and functionalities (such as excessive triggering 
of alerts, long lists of medication, default dosing func-
tionality, limited dosing scales or forced sequences of 
field completion and navigation across screens, views 
and overviews) were perceived to increase the risk of 
specific errors.
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Positive organisational implications
Although most included studies focused on benefits/
problems of ePrescribing/CPOE in practice, some 
highlighted broader organisational issues.
Positive organisational implications had to do with 
the cost-effectiveness of the monitoring potential 
afforded by ePrecribing/CPOE technologies for quality 
and safety assurance purposes45 48 51 52 77 93 alongside 
its potential for financial efficiency43 55 93 and the 
positive impact on institutional reputation associ-
ated with being seen as a technologically advanced 
organisation.43
Negative organisational implications
Some studies reported a sense of distrust from clini-
cians towards some drivers expressed from a managerial 
perspective. For example, some studies reported clini-
cians perceiving ePrescribing/CPOE to be more advan-
tageous to managers/administrators and imposed on 
them rather than driven by genuine clinical needs.51 52 
Other studies reported clinicians’ concerns relating to 
the use of data generated by the ePrescribing/CPOE 
system for surveillance and performance management 
purposes.20 77 93
The lack of integration with other existing health 
information technology systems was perceived as a 
barrier to effective and reliable information transfer 
across coexisting systems in hospitals. Moreover, such 
lack of integration was seen to introduce risks (such as 
the potential for duplication associated with manual 
data entry across systems) that can hinder the avail-
ability of timely and complete data and compromise 
the ability of an organisation to realise the full poten-
tial of ePrescribing/CPOE systems.23 43 49 51 55
Other perceived problems included a lack of 
organisational policies, management practices and 
standards of practice that address/support new or 
changing procedures and workflows after implemen-
tation.66 67 71 86
Mixed impacts and change processes
Beyond the benefits-and-problems rationale 
employed by most studies to describe the impact 
of implementing ePrescribing/CPOE in hospitals, 
papers also reported on what we have called ‘mixed 
impacts and change processes’, that is, impacts that 
cannot be easily framed as ‘positive’ or ‘negative’ per 
se but are better understood as ‘differences’ from 
whatever there was prior to implementation and as 
such they have the potential to result in either posi-
tive or negative implications, or both (or neither), in 
different contexts.
Change in practice
The main transformations reported by studies involved 
changes in work practices, particularly around work-
flows, interactions and communication:
 ► Workflow-related transformations included changes 
in aspects such as work pace, sequence and 
dynamics18 57 81 85 88 93 94 that can reshape the factors 
leading to medication errors71 95 and impact on many 
other specific aspects of everyday practice for doctors 
(eg, changes in the sequence and nature of cognitive 
tasks physicians undertake when admitting a patient 
to hospital)96 as well as nurses (eg, ability to document 
that a medication was given becomes subject to system 
access and log-in)67 71 and pharmacists (eg, shift in docu-
mentation and annotation practices, particularly due to 
systems’ built-in drug information).70 71 97 98
 ► Interaction-related transformations included a perceived 
increased interdependence resulting from changes in 
the frequency, volume and/or nature of staff-staff inter-
actions (eg, between doctors and nurses or between 
pharmacists and doctors)42 43 47 63 71 83 86 88 98 99 and staff–
patient interactions (eg, pharmacist–patient or doctor–
patient interactions).16 86 93 98 100
 ► Communication-related transformations included 
changes in interprofessional communication patterns, 
task coordination and flow of information (eg, phar-
macy–clinician or doctor–nurse communication, commu-
nication between administration and clinical staff and 
communication between shifts)24 43 51 52 65 67 71 74 80 94 101–104 
including changes in the educational experiences in 
teaching/academic hospitals105 as well as changes in 
patient communication.86 88 98 100 101
These changes, alongside the need to accom-
modate idiosyncrasies of the systems them-
selves, were perceived to have shifted professional 
roles47 63 65 71 79 83 88 95 97 98 102 103 106 107 that often trans-
lated into the emergence of a wide range of work-
arounds9 16 18 22 48 49 51 61 66 74 78 84 88 92 93 108 across all 
the stages of the medication process.
Change at the organisational level
CPOE/ePrescribing systems were perceived to shift 
governance practices, bringing in new ways to handle 
and enact organisational power and organisational 
politics.43 47 51 52 57 93 For example, choosing a system 
and devising an implementation strategy can enable 
those leading on its implementation to influence the 
distribution of its advantages and disadvantages within 
the organisation43 by focusing more on particular 
processes’ or stakeholders’ needs over others (eg, 
doctors over pharmacists or managers over clini-
cians).47 51 52 71
Other studies reported how ePrescribing/CPOE 
systems enable the generation of, and access to, new 
data and metrics about individuals, teams, services and 
organisations9 20 47 62 93 to inform service evaluation 
and improvement, but with the proviso that appro-
priate strategies and resources for data monitoring, 
analysis and follow-up had to be in place to enable 
improvements.62 92 109
CPOE/ePrescribing systems can introduce or high-
light discrepancies between established processes/
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policy/guidelines and practice under the newly imple-
mented system48 64 83 85 92 95 the extent and nature 
of which are perceived and experienced differently 
across different clinical contexts.51 52 94 Such gaps 
were addressed by organisations by either performing 
modiﬁcations to the system to realign practice and 
processes/policy/guidelines47 66 93 and/or by making 
adjustments to current processes/policy/guide-
lines,9 46 66 81 including the temporary formalisation 
of emerging workarounds to mitigate known system 
limitations that were perceived as patient safety risks.22
dIscussIon
We carried out a thematic synthesis of 79 papers to 
examine how stakeholders experience the adoption of 
ePrescribing/CPOE systems in hospitals.
Stakeholders’ perspectives revealed a mixed set of 
impacts that collectively do not clearly frame ePre-
scribing/CPOE as resulting in either an improvement 
or a deterioration of the quality and safety of hospital 
services. Instead, our findings reveal coexisting bene-
fits and problems, which often overlap and coun-
terbalance each other in the context of competing 
impacts and further-reaching, more complex changes. 
Taken together, these can be understood as an illus-
tration of cultural shifts that reframe and recast the 
issues and challenges of the medication-related aspects 
of quality and safety in hospitals.110 Implementation 
strategies should explicitly and integrally address the 
change processes triggered by the adoption of ePre-
scribing/CPOE, both in practice and at the organisa-
tional levels, rather than focusing solely on discrete 
benefits/problems, recognising such changes are multi-
faceted, highly contingent on multiple perspectives 
and context dependent.
To address this, implementing organisations and 
teams could call on available implementation theories, 
models and frameworks28 29 to inform their imple-
mentation strategies, as well as research specifically 
addressing change processes and contextual factors 
involved in the adoption of ePrescribing/CPOE in 
hospitals. Although studies included in this review have 
largely focused on benefits/problems of ePrescribing/
CPOE rather than the change processes underpinning 
them, these processes are well documented across 
included studies (eg, ref 22) and have the potential 
to inform future implementation strategies through a 
more comprehensive understanding of the impact of 
ePrescribing/CPOE.5 71
Only a few studies examined the implementation 
and impact of ePrescribing/CPOE taking into account 
factors and/or actions undertaken prior to implementa-
tion. However, these would suggest that more attention 
(and appropriate allocation of resources) to preimple-
mentation considerations,111 112 including appropriate 
contextualisation of implementation strategies with 
specific reference to organisational and stakeholder 
groups needs and agendas, should facilitate successful 
implementation.44 45 Furthermore, echoing the socio-
technical nature of ePrescribing/CPOE, our findings 
suggest that assessing and responding to organisa-
tional and stakeholders’ needs should be treated as 
an ongoing, emergent feature of ePrescribing/CPOE 
adoption.
Our findings suggest drivers for implementing 
ePrescribing/CPOE in hospitals cannot be straight-
forwardly explained by the benefits experienced by 
those involved in their everyday use. Risks and safety 
concerns have been reported throughout the period 
covered by this review, in keeping with previous find-
ings.10 While most included studies focused on clini-
cians’ perspectives, their needs have not been centrally 
addressed in ePrescribing/CPOE implementations. 
Conversely, little attention has been paid to the broader 
organisational issues, including potentially powerful 
drivers and factors from a managerial or health-sys-
tems perspective. Instead, most reported impacts were 
practice related. An in-depth knowledge of incentives 
and drivers of a political, financial, corporate or mana-
gerial nature could have helped explain why clinicians’ 
needs may not have been central to ePrescribing/CPOE 
implementations and contextualise the practice-related 
impacts of ePrescribing/CPOE adoption in hospitals, 
so that they can be better understood, explained and 
researched. It follows that organisational transparency 
on the intended direction of change in clinical practice 
and at the organisational level, and seeking, manage-
ment and balancing of different stakeholder perspec-
tives throughout ePrescribing/CPOE adoption journey, 
should help implementing organisations to address 
potential negative implications and promote beneficial 
contextual factors.
A further research gap was the limited number 
of studies drawing on patients’ or carers’ 
views.21 45 62 72 89 100 109 These could provide valuable 
insights related to key aspects of ePrescribing/CPOE 
systems in practice, such as shifts in communication/
interaction patterns100 and the involvement of patients/
carers in medication safety,112 including the examina-
tion of ePrescribing/CPOE as a potential barrier to 
patients/carers accessing their own prescriptions while 
in hospital. This is needed to understand the impact of 
ePrescribing/CPOE on enacting patient-centred care, 
in particular, the fundamental tenet of acknowledging 
and valuing patients’/carers’ experiential knowledge. 
Patients, particularly those with multimorbidity and 
polypharmacy, see their care managed under multiple 
or changing systems over time and/or across settings. 
Implementing organisations and teams should seek 
and address patient and carer views and experiences to 
ensure patient-centred care is maintained and patient 
satisfaction sustained during system implementation 
and optimisation.
Our review has limitations. Variable reporting 
quality of included papers reduced our ability to 
consider contextual information about specific settings 
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and/or systems and to accurately assess quality. We did 
not carry out quantitative inter-reviewer reliability 
assessments. Instead, we ensured reliability and consis-
tency across reviewers by systematically discussing all 
disagreements, involving additional reviewers when 
required to achieve consensus. In this secondary anal-
ysis, another important limitation was the restricted 
access to primary data: our findings draw on authors’ 
interpretations in articles’ results sections and any illus-
trative quotes reported to support them. We sought 
to provide an integrative understanding of ePre-
scribing/CPOE systems from stakeholders’ experiences 
drawing on multiple perspectives that have engaged 
from different angles with similar interventions in 
secondary care contexts. We noted if and how any 
key differences in characteristics (such as stakeholder 
or system type) translated into any salient aspects of 
this multiperspective narrative but acknowledge that a 
reporting focusing on these differences might also be 
of interest.
conclusIons
The adoption of ePrescribing/CPOE in hospitals can 
be understood as cultural shifts that reframe the medi-
cation-related aspects of quality and safety, featuring 
coexisting benefits and problems. Implementing 
organisations and teams should consider the breadth 
and depth of changes that ePrescribing/CPOE adop-
tion can trigger rather than focus on discrete benefits/
problems and favour implementation strategies that: 
consider the preimplementation context; are respon-
sive to (and transparent about) organisational and 
stakeholder needs and agendas; and can be sustained 
effectively over time as implementations develop and 
gradually transition to routine use and system opti-
misation. Alongside this, patients’ views and experi-
ences should be sought throughout to ensure sustained 
patient satisfaction during system implementation and 
avoid unintended negative consequences on the organ-
isations’ ability to enact patient-centred care.
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